Pharmafile Logo
Pharmafocus logo
Advanced Search

Memorial Sloan Kettering Chief resigns from MSD board

October 3, 2018
Research and Development MSD, Memorial Sloan Kettering Cancer Center, pharma

Dr Craig Thompson, Chief Executive of Memorial Sloan Kettering Cancer Center (MSKCC), the renowned non-profit treatment and research institution based …

News
4768764591_9e4f7f0eb8_z

Clinical trial halted because of Brexit, UK Government downplays concerns

October 3, 2018
Research and Development UK, brexit, clinical trials, politics, research

A clinical trial looking into the safety and efficacy of the drug dutogliptin has been halted due to uncertainties surrounding …

News
shutterstock_243110086

No link between progression-free survival benefits and improved quality of life, study argues

October 2, 2018
Manufacturing and Production, Research and Development Cancer, clinical trials, pharma

A study of randomised clinical trials, conducted by Canada’s McMaster University and published in the Journal of the American Medical …

News
shutterstock_114045100

African-American enrollment disproportionately high in no-consent trials

October 2, 2018
Manufacturing and Production, Research and Development FDA, clinical trials, pharma, transparency

A new study has revealed that African-American citizens make up a disproportionately high share of participants in US clinical trials …

News
acute_lymphoblastic_leukaemia_smear

20 year old man died after leukaemia cell was accidently mixed into CAR T therapy

October 2, 2018
Manufacturing and Production CAR T, CAR-T, Cancer, Kymriah, Novartis, leukaemia, oncology

A 20 year old man died after a single leukaemia cell accidentally ended up in a batch of cells that …

News
12308739253_f11096e120_b

Nobel Prize awarded to immuno-oncology innovators

October 2, 2018
Manufacturing and Production Cancer, Nobel Prize, immunotherapy, kyoto, oncology, texas

The Nobel Prize for physiology or medicine has been awarded to both Professor James P Allison and Tasuku Honjo for …

News
ianread

Pfizer CEO Ian Read set to step down from head position

October 1, 2018
Manufacturing and Production, Sales and Marketing Albert Bourla, CEO, COO, Ian Read, Pfizer, Stock Markets

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …

News
shutterstock_235920349

Are biosimilars key to solving NHS access concerns?

October 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Pfizer, UK, biosimilars, celltrion, pharma

In light of continued austerity gripping the NHS, it was uplifting to hear in July that the health service had …

Feature

European countries unprepared for Alzheimer’s innovations, study shows

October 1, 2018
Sales and Marketing Alzheimer's dementia, Alzheimer’s & dementia, EU, Euroepan Union, RAND corporation, research

European healthcare systems are not prepared for new developments in preventative therapies for Alzheimer’s disease, according to research conducted by …

News
nhs_sign

NHS England to fund availability of Janssen’s single tablet HIV combo Symtuza

October 1, 2018
Sales and Marketing HIV, Janssen, NHS, Symtuza, pharma

Great news for HIV patients in the UK as Janssen reveals that NHS England will provide critical funding for its …

News
novo_nordisk_flag

Novo Nordisk cuts 650 roles around the world in R&D restructure

October 1, 2018
Manufacturing and Production, Sales and Marketing China, Denmark, Novo Nordisk, UK, US, pharma

Novo Nordisk has announced a wave of jobs cuts as part of a global restructure of its $1 billion R&D …

News
800px-t_lymphocyte_16760076824

Antibody therapy supresses HIV for months after treatment, study shows

October 1, 2018
Sales and Marketing HIV, immunology, immunotherapy, nature, research

Researchers from the New York City based Rockefeller University have developed a novel immunotherapy, which is capable of suppressing HIV …

News

Roche acquires immuno-oncology biotech Tusk in €655m deal

October 1, 2018
Sales and Marketing Droia, Roche, Tusk, immuno-oncology, immunology, oncology

Swiss multinational Roche has acquired the privately held immuno-oncology company Tusk Therapeutics in a deal that could be worth up …

News
mcewan

Ipsen appoints two leading R&D experts in bid to strengthen oncology arm

September 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, R&D, development, ipsen, oncology, research

French pharma firm Ipsen has announced the appointment of Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic …

Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, NHS, Novartis, pharma

Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …

News
novartis_window

Novartis strike $40m deal with Chinese firm Cellular Biomedicine

September 28, 2018
Medical Communications CAR T, CAR-T, China, Kymriah, Novartis, cellular biomedicine, prc

Swiss multinational Novartis have paired up with Chinese drugmaker Cellular Biomedicine (CBMG) in order to manufacture CAR-T therapy Kymriah in …

News
gilead-sciences

Gilead to release generic versions of hep C meds over a decade before patent expiry

September 28, 2018
Medical Communications, Sales and Marketing Epclusa, Gilead, generics, harvoni, hepatitis C, pharma

Gilead has announced its intention to undercut itself by releasing generic versions of its blockbuster drugs for the treatment of …

News
cow_field_farm_nature_agriculture_green_meadow_animal-1278036

UK government accused of using Brexit to avoid antimicrobial resistance ruling

September 28, 2018
Medical Communications AMR, Antibiotics, UK, WHO, antimicrobial resistance, farming, politics

The British government has been accused of using Brexit to avoid implementing new EU legislation preventing powerful antibiotics from be …

News
darpa_big_data

Percentage of life sciences professionals using blockchain has tripled since 2017

September 27, 2018
Medical Communications blockchain, pharma, pistoia alliance, technology

A survey conducted by The Pistoia Alliance, a not-for-profit coalition of life science companies, vendors, publishers and academic groups, has …

News
shutterstock_273326141

Novartis joins forces with GARDP for better, accessible infectious disease treatments in the developing world

September 27, 2018
Research and Development, Sales and Marketing GARDP, Novartis, infectious disease, pharma

Novartis has partnered up with the Global Antibiotic Research & Development Partnership (GARDP) to push for faster development and wider …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026